Skip to main content
. 2023 May 8;14:1153462. doi: 10.3389/fendo.2023.1153462

Table 1.

Baseline characteristics of participants with respect to urinary iodine.

Characteristics Total Low UIC (<100ug/L) Normal UIC (100-299ug/L) High UIC (300-399ug/L) Very high UIC (≥400ug/L) P-value
11545 4064 5507 835 1139
UIC, (ug/L) 187.86±3.28 60.14±0.51 175.96±1.03 343.55±1.51 627.15±7.87 < 0.001
Age, (Years) 47.12±0.30 45.26±0.37 47.67±0.40 49.88±0.74 49.58±0.67 < 0.001
Gender, (%) < 0.001
Female 5740(49.7) 2218(55.5) 2631(48.4) 375(45.3) 516(45.2)
Male 5805(50.3) 1846(44.5) 2876(51.6) 460(54.7) 623(54.8)
Ethnic, (%) 0.004
Mexican American 1813(15.7) 586(7.7) 936(9.2) 129(7.8) 162(7.6)
Non-Hispanic Black 2368(20.5) 889(10.9) 1137(11.1) 138 (8.0) 204 (9.3)
Non-Hispanic White 5138(44.5) 1726(68.5) 2413(68.2) 422(74.9) 577(71.5)
Other Race 2226(19.3) 863(12.9) 1021(11.4) 146 (9.3) 196(11.6)
Education levels, (%) 0.02
Above high school 5940(51.5) 2182(62.3) 2794(58.4) 425(60.0) 539(57.4)
Below high school 2875(24.9) 899(13.9) 1441(17.1) 213(16.3) 322(18.2)
High School Grad/GED or Equivalent 2730(23.6) 983(23.8) 1272(24.5) 197(23.6) 278(24.4)
Income, (%) < 0.001
Above 20000$ 9116(79) 3268(87.5) 4363(86.2) 651(86.5) 834(81.4)
Below 20000$ 2429(21) 796(12.5) 1144(13.8) 184(13.5) 305(18.6)
Alcohol drinking, (%) < 0.001
Heavy 2386(20.7) 883(22.6) 1114(22.0) 165(19.2) 224(22.7)
Mild 3798(32.9) 1339(35.8) 1858(37.2) 266(36.6) 335(32.6)
Moderate 1820(15.8) 735(20.9) 815(16.7) 123(16.1) 147(12.3)
No 3541(30.7) 1107(20.7) 1720(24.1) 281(28.1) 433(32.5)
Smoking, (%) 0.08
Former 2922(25.3) 961(24.9) 1420(25.3) 220(24.3) 321(28.6)
Never 6221(53.9) 2194(53.3) 2982(55.1) 457(57.5) 588(53.4)
Now 2402(20.8) 909(21.8) 1105(19.6) 158(18.3) 230(18.0)
Physical activity, (Met) 567.6±14.3 532.6±20.8 596.2±22.5 612.0±49.3 529.7±29.8 0.11
Energy, (kcal) 2189.0±12.0 2157.4±21.6 2196.5±16.8 2305.3±36.4 2184.1±38.2 0.01
Sodium intake, (mg/d) 3579.0±22.8 3547.2±35.4 3603.0±32.3 3695.5±78.5 3492.5±66.1 0.22
Fish and shellfish intake, (%) 0.03
No 2290(19.8) 814(18.7) 1052(18.3) 158(18.7) 266(23.3)
Yes 9255(80.2) 3250(81.3) 4455(81.7) 677(81.3) 873(76.7)
Waist, (cm) 99.19±0.28 96.67±0.33 100.36±0.38 101.98±0.72 101.12±0.61 < 0.001
OGTT glucose, (mmol/L) 7.29±0.06 7.06±0.09 7.36±0.08 7.57±0.17 7.64±0.19 0.003
Fasting glucose, (mmol/L) 5.93±0.02 5.84±0.04 5.96±0.03 6.04±0.09 6.04±0.09 0.01
HbA1c, (%) 5.62±0.01 5.56±0.02 5.64±0.02 5.70±0.05 5.70±0.04 < 0.001
eGFR 94.89±0.45 97.19±0.61 94.06±0.47 91.54±0.95 92.65±0.85 < 0.001
Uric acid, (umol/L) 324.43±1.24 318.82±2.05 328.97±1.72 327.93±3.19 321.39±3.42 < 0.001
TG, (mmol/L) 2.73±0.03 2.64±0.05 2.73±0.05 2.89±0.12 2.96±0.10 0.03
Total cholesterol, (mmol/L) 5.02±0.02 5.04±0.02 5.02±0.02 4.96±0.05 4.95±0.05 0.23
HDL, (mmol/L) 1.38±0.01 1.43±0.01 1.36±0.01 1.32±0.02 1.31±0.02 < 0.001
LDL, (mmol/L) 2.42±0.01 2.43±0.03 2.44±0.02 2.34±0.04 2.32±0.04 0.02
TSH, (mIU/L) 1.95±0.04 1.98±0.10 1.91±0.06 1.98±0.04 1.91±0.06 0.661
FT4, (ug/dL) 7.98±0.03 8.00±0.09 8.00±0.04 7.96±0.04 7.99±0.07 0.824
SBP, (mmHg) 121.8±0.3 121.3±0.4 121.9±0.4 122.6±0.6 122.4±0.7 0.42
DBP, (mmHg) 70.98±0.22 71.56±0.32 70.62±0.24 70.26±0.60 71.01±0.45 0.02
Cancer, (%) 0.001
No 10401(90.1) 3754(91.6) 4928(89.5) 723(85.5) 996(89.2)
Yes 1144(9.9) 310 (8.4) 579(10.5) 112(14.5) 143(10.8)
Thyroid disease, (%) 0.002
No 10329(89.5) 3711(90.0) 4915(88.9) 729(86.5) 974(85.2)
Yes 1216(10.5) 353(10.0) 592(11.1) 106(13.5) 165(14.8)

UIC, urinary iodine concentration. MetS, metabolic syndrome; HbA1c, eGFR, Glomerular filtration rate; TG, triglyceride; HDL, high-density lipoprotein;

LDL, low-density lipoprotein; SBP, Systolic blood pressure; DBP, Diastolic blood pressure;

Data are presented as means (standard error), or weighted percentages as appropriate for the variable. Demographic and biochemical characteristics of the study population for Continuous normal variables were expressed as weighted mean ± standard deviation, One-way ANOVA was used to compare differences between groups. Categorical variables were expressed as frequencies and percentages and compared using Rao Scott’s χ2 test.